Records 1 - 4
| Pharmacogenetic associations of NRG1 polymorphisms with neurocognitive performance and clinical symptom response to risperidone in the untreated schizophrenia.
Schizophrenia research 2021 Mar 231 67-69.
Yang JianZhong, Kang ChuanYuan, Wu Changjiang, Lin Yuanyuan, Zeng Lei, Yuan Jing, Zhang Yan, Wei YuJun, Xu Li, Zhou Fa
| Identifying the genetic risk factors for treatment response to lurasidone by genome-wide association study: A meta-analysis of samples from three independent clinical trials.
Schizophrenia research 2018 May .
Li Jiang, Loebel Antony, Meltzer Herbert
| Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families.
Psychiatric genetics 2012 Apr 22 (2): 70-81.
Yokley Jessica L, Prasad Konasale M, Chowdari Kodavali V, Talkowski Michael E, Wood Joel, Gur Ruben C, Gur Raquel E, Almasy Laura, Nimgaonkar Vishwajit L, Pogue-Geile Michael
| Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level.
Biological psychiatry 2007 Oct 62 (7): 784-92.
Stefanis Nicholas C, Trikalinos Thomas A, Avramopoulos Dimitrios, Smyrnis Nikos, Evdokimidis Ioannis, Ntzani Evangelia E, Ioannidis John P, Stefanis Costas